You, your family or your patient may be eligible for one or more of these protocols. To speak with one of our counselors, please e-mail them or call (614) 293-6694 or toll-free 1-888-329-1654, Monday through Friday, 8 a.m. - 5 p.m. EST.
General Study & Clinical Testing Consents & Forms
|Number||Title||Eligibility Criteria||Study Coordinator|
|2010H0072||Ohio State University Medical Center: Coriell Personalized Medicine Collaborative Study||Patients with a diagnosis of systolic heart failure or newly-diagnosed hypertension who are receiving medical care from one of the cardiologists or internal medicine physicians also participating in the study.|
|0788||The Columbus Breast Tissue Bank||Women with invasive breast cancer diagnosed in Columbus, Ohio.||Rob Pilarski|
|07014||Genetic modifiers of Breast & Ovarian Cancer Risk||
Please contact Leigha Senter for details.
|05082||Variants in High Risk Breast Cancer Genes and Contribution to Cancer Risk.||Please contact Leigha Senter for details.||Leigha Senter|
|0107||Prospective cohort study on BRCA1 and BRCA2 carriers||Please contact Leigha Senter for details.||Leigha Senter|
|06032||The Endocrine Neoplasia Repository||Any individual with thyroid cancer or benign thyroid disease being treated at The Ohio State University Medical Center/ James Cancer Hospital.||Rebecca Nagy|
|9812||Strategy to search for genes predisposing to papillary carcinoma of the thyroid when mutated.||At least two cases of papillary thyroid cancer (PTC) in close relatives.||Rebecca Nagy|
|06036||The Genetics of Hereditary Uveal Melanoma.||
Patients with a current or past diagnosis of uveal (eye) melanoma. Contact Rob Pilarski for details.
|05078||Genomic Analysis of Squamous Cell Carcinoma||Please contact Dawn Allain for details.||Dawn Allain|
|9952||Human Cancer Genetics Sample Banking Protocol||
Please contact Ilene Lattimer for details.
|N/A||American Founder Mutation Study||Aims to describe prevalence of a large genomic deletion encompassing exons 1 to 6 of the MSH2 gene that is widespread in the U.S population as a result of a founder effect. Click here for details on American Founder Mutation (AFM) families and publications.||Heather Hampel|
|N/A||Hyperplastic Polyposis Study||A cohort study of patients with unusual colon polyp histology (i.e. mixed polyposis) for which we hope to identify and correlate with alterations in known and putative cancer susceptibility gene(s) and pathways of polyp formation. Tumor blocks are requested and reviewed, gene analysis is primarily done through research collaborations.||Kevin Sweet|
|06070||Genetics, Molecular Diagnostics, and Mechanisms of Juvenile Cobalamin Deficiency (JCD)||
Individuals with a known or suspected diagnosis of juvenile cobalamin deficiency (as specified by their clinician), are between the ages of 1 and 99 years and/or are an affected or unaffected relative of an individual diagnosed with juvenile cobalamin deficiency.
|05090||Storage of biological material for the discovery and characterization of genes involved in hereditary disease predisposition||
Determined by the Medical Genetics Program.
|N/A||Cardiovascular Genetics Data Repository||Males or females who are 18 years of age or older with either:
1) A personal diagnosis of a cardiovascular genetic condition (familial aneurysm, familial cardiomyopathy, familial dysrhythmia, familial hypercholesterolemia, early-onset CAD (males <55 or females <65), etc.) and/or
2) A family history of one of the above conditions or a family history that classifies them as being at increased familial risk for CAD.